An advanced device for better insulin delivery in diabetes management
Official title: A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy
Funded at Wayne State University · NIH-10928819 · Data updated 2026-11-12
This study is working on a new way to deliver insulin for people with diabetes that could help reduce skin irritation and make insulin devices last longer, so you can have a better experience managing your condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project start | September 15, 2023 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $649,049 |
| NIH project number | 5R01DK133789-02 |
| Project ID | NIH-10928819 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with diabetes who require insulin therapy and are experiencing issues with current insulin delivery methods.
✕Less likely to help
Patients who do not use insulin or those with diabetes types that do not require insulin therapy may not benefit from this research.
What this research studies
This research focuses on improving the technology used for delivering insulin to patients with diabetes. It aims to address issues related to tissue damage caused by preservatives in current insulin formulations, which can limit the effectiveness of insulin delivery devices. By developing a new inline platform, the research seeks to extend the wear time of insulin delivery devices, aligning them with the longer-lasting continuous glucose monitors. This could potentially reduce inflammation and improve the overall experience for patients managing their diabetes.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective insulin delivery methods, enhancing diabetes management for patients.
How similar studies have gone: Previous research has shown promise in improving insulin delivery technologies, but this approach aims to tackle specific challenges that have not been fully addressed before.
Where this research is happening
-
Wayne State University
Detroit, United States Active
Researchers
- Principal investigator: Klueh, Ulrike — Wayne State University
- Study coordinator: Klueh, Ulrike
Related research
Other NIH-funded projects on the same topics.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Bringing WHO HEARTS-D diabetes care into Bangladesh cities
A program to help urban clinics in Bangladesh adopt WHO HEARTS-D guidelines to improve detection, treatment, and control of type 2 diabetes.
-
AI-powered fundus imaging to screen for type 2 diabetes
A mobile AI tool uses eye images to help screen adults for type 2 diabetes in clinics or communities.
-
AI-powered eye imaging to screen for type 2 diabetes with a mobile phone
A plan to use AI on smartphone retinal images to help spot type 2 diabetes early, especially in people who may not have easy access to care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.